{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:47:52Z","timestamp":1771062472121,"version":"3.50.1"},"reference-count":62,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Xenobiotica"],"published-print":{"date-parts":[[2025,4,21]]},"DOI":"10.1080\/00498254.2025.2518239","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T13:25:38Z","timestamp":1749648338000},"page":"317-328","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Quantitative prediction of drug-drug interactions arising from CYP3A4 induction using chimeric mice with humanized liver"],"prefix":"10.1080","volume":"55","author":[{"given":"Keigo","family":"Nakayama","sequence":"first","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamotsu","family":"Negoro","sequence":"additional","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Takubo","sequence":"additional","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Hayashi","sequence":"additional","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Nomura","sequence":"additional","affiliation":[{"name":"DMPK Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences","place":["Takatsuki, Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803020-00002"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00179-X"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.122.001000"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000361"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12275"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/074823379701300401"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00461-06"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(24)15284-1"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-3"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2015.07.002"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2009.137"},{"issue":"2","key":"e_1_3_4_13_1","first-page":"141","article-title":"Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes","volume":"29","author":"Easterbrook J","year":"2001","unstructured":"Easterbrook J, Lu C, Sakai Y, Ap L. 2001. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab Dispos. 29(2):141\u2013144.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.124.001792"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000276"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2008.09.002"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12343"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.042754"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1860"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50128-z"},{"key":"e_1_3_4_21_1","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals For Human Use Ich Harmonised Guideline Drug Interaction Studies M12. 2024. ICH harmonised guideline: drug interaction studies M12."},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-009-9099-y"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2023.2280785"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007509324428"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.017418"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-019-0341-y"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.001347.drug"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.005157"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12088"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.276"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199410000-00003"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03201.x"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2447"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000333"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm049711o"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.123.001398"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16270"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.123.001595"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy201"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/v12121382"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1460516"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847100-00004"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200105000-00003"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.119.087270"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.047555"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1007112"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2020.1769229"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3565(25)22379-5"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.124.001876"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(96)90177-0"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.121.000497"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00578"},{"key":"e_1_3_4_53_1","volume-title":"FDA - Clinical reviews of rilpivirine","author":"U.S. Food and Drug Administration","year":"2011","unstructured":"U.S. Food and Drug Administration. 2011. FDA - Clinical reviews of rilpivirine. NDA 202022. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=202022."},{"key":"e_1_3_4_54_1","volume-title":"FDA - Clinical reviews of simeprevir","author":"U.S. Food and Drug Administration","year":"2013","unstructured":"U.S. Food and Drug Administration. 2013. FDA - Clinical reviews of simeprevir. NDA 205123. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&varApplNo=205123."},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.711"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2021.100410"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm901371v"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-018-4331-x"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1293\/tox.2021-0027"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070330"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.2174\/138920008784746382"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01120-08"}],"container-title":["Xenobiotica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/00498254.2025.2518239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:05:22Z","timestamp":1753178722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/00498254.2025.2518239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,21]]}},"alternative-id":["10.1080\/00498254.2025.2518239"],"URL":"https:\/\/doi.org\/10.1080\/00498254.2025.2518239","relation":{},"ISSN":["0049-8254","1366-5928"],"issn-type":[{"value":"0049-8254","type":"print"},{"value":"1366-5928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ixen20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}